Physician profile
Victor M Costa
NPI 1053707638
$11,311.92
in general payments reported to CMS, 2019-2025
17 companies · $2,481 in 2025
The $2,481 reported for 2025 was more than what 84% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $2,276 · 2024: $6,555 · 2025: $2,481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,451 · Education: $4,000 · Food and Beverage: $2,861.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,450.79 |
| Education | $4,000.00 |
| Food and Beverage | $2,861.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,402.66 | 2023-2025 | Davinci Xi, Da Vinci Surgical System |
| Medical Device Business Services, INC. | $1,607.77 | 2024 | Echelon Flex |
| Boston Scientific Corporation | $1,549.97 | 2024-2025 | Apollo Esg Nxt System, Accolade Sr, Spyglass Discover |
| Tela Bio, INC. | $1,291.20 | 2023-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Medtronic, INC. | $411.62 | 2023-2024 | Endoflip, Signia |
| Davol INC. | $240.11 | 2024-2025 | Phasix Mesh |
| Ethicon US, LLC | $176.09 | 2024 | Echelon; Endopath, Echelon Endopath |
| Stryker Corporation | $155.80 | 2025 | 1788 |
| Phathom Pharmaceuticals, INC. | $153.51 | 2024-2025 | Voquezna |
| Acera Surgical, INC. | $114.52 | 2023-2025 | Restrata Wound Matrix |
| Lilly USA, LLC | $82.09 | 2025 | Zepbound, Mounjaro |
| Vertex Pharmaceuticals Incorporated | $38.12 | 2025 | |
| Novo Nordisk INC | $23.14 | 2025 | Wegovy |
| Takeda Pharmaceuticals U.S.A., INC. | $21.10 | 2023 | Gattex |
| Lifenet Health | $16.04 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mesh Suture INC | $14.18 | 2024 | |
| Rhythm Pharmaceuticals, INC. | $14.00 | 2023 | Imcivree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor Costa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.